However, the use of rifaximin containing polymorphic forms other than the α-form, in particular the amorphous form, could lead to quite significant adverse effects when taken in the medium or long term.
1
—
—
However, the use of rifaximin containing polymorphic forms other than the α-form, in particular the amorphous form, could lead to quite significant adverse effects when taken in the medium or long term.